Mesenchymal Stem Cells and Other Options for Managing Arthritis
Arthritis impacts more than a quarter of adults in the United States. Learn more about your options for managing this disorder in this post.
Arthritis impacts more than a quarter of adults in the United States. Learn more about your options for managing this disorder in this post.
GIOSTAR CEO and Co-Founder Deven Patel spoke on the most downloaded episode of the “Exploring Leadership” podcast, hosted by military veteran Spence Taylor
GIOSTAR has continuously set the bar for innovation in cancer research. The firm was recently recognized with a prestigious award, given to only 9 other researchers.
Looking to educate yourself about Fluid Flow Treatment? The amniotic fluid allograft being offered by GIOSTAR is just the latest example of our commitment to innovation in healthcare.
Are you suffering from neuropathy? Stem cell therapy is showing promise as a solution for neuropathic pain. Learn more here.
GIOSTAR recently treated a patient suffering from COVID-19 with stem cells. He experienced considerable improvement following this procedure. A placebo-controlled, double-blind study would be needed to better understand the measurable outcome of stem cell treatment for COVID-19.
Dr. Anand Srivastava, Deven Patel, Dr. Amy Killen, and Dr. Kyle Bergquist take part in a fascinating mini-documentary entitled Age of Cells. The program features extensive interviews with Dr. Srivastava and Mr. Patel, excerpts from lectures, and a sweeping tour of India.
Learn more about multiple sclerosis, and how stem cell therapy may provide symptomatic relief for patients suffering from this neurodegenerative disease.
GIOSTAR Chairman and Co-Founder Dr. Anand Srivastava recently spoke with Healthcare Weekly about stem cells, COVID-19, and numerous other topics.